CRSP — CRISPR THERAPEUTICS AG
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
As of Q2 2026, 537 SEC-registered investment managers reported holding CRSP (CRISPR THERAPEUTICS AG) in their latest 13F filings, with a combined reported value of $5.64B across 79.61M shares. That is -4.5% by share count (-3.51M shares) versus the previous quarter, while reported value moved +44.8%. Ownership is concentrated: the five largest holders account for 50.3% of reported value and the top ten for 64.9%.
Compared with the prior quarter, 78 opened new positions, 155 added to existing stakes, 145 trimmed, 52 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
Major shareholders of CRISPR THERAPEUTICS AG (CRSP) include ARK Invest, BlackRock Inc, Orbis Allan Gray Ltd, ranked by reported 13F value among the 975 institutional holders on this page.
CRSP is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Legendary Investors Holding CRSP
The superinvestors we track who report CRSP in their latest 13F filing — each shown at that manager’s own most recent quarter.
| Investor | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
|
|
Q3 2026 | 10.06M | $556.34M | 3.22% | Add |
Which stocks do these investors own together? → · Embed this widget →
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 413 | 53.73M | $2.97B | +5.4% |
| Q2 2026 | 537 | 79.61M | $5.64B | -4.7% |
| Q1 2026 | 507 | 83.35M | $3.96B | -3.7% |
| Q4 2025 | 500 | 77.41M | $4.06B | +4.3% |
| Q3 2025 | 461 | 71.03M | $4.60B | +6.4% |
| Q2 2025 | 443 | 67.88M | $3.31B | +7.0% |
| Q1 2025 | 395 | 63.58M | $2.16B | +3.6% |
| Q4 2024 | 398 | 61.20M | $2.41B | +5.0% |
Over the 8 quarters shown, institutional share counts decreased 12% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q2 2025 (+7.0%).
Top Institutional Holders (Q3 2026) — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 10.06M | $556.34M | 3.22% | Add | |
| 8.30M | $459.15M | 0.01% | Reduce | |
| 4.99M | $276.27M | 0.01% | Add | |
| 4.74M | $262.17M | 0.03% | Hold | |
| 2.61M | $144.30M | 29.03% | Reduce | |
| 2.51M | $139.00M | 0.01% | Hold | |
| 1.90M | $104.93M | 0.01% | Reduce | |
| 1.45M | $80.42M | 0.05% | Reduce | |
| 1.45M | $80.36M | 1.00% | Reduce | |
| 1.27M | $70.05M | 0.01% | Hold | |
| 1.25M | $69.07M | 0.03% | Add | |
| 1.17M | $64.73M | 0.00% | Reduce | |
| 842.11K | $46.59M | 0.00% | Reduce | |
| 649.73K | $35.94M | 0.00% | Hold | |
| 573.55K | $31.73M | 0.01% | Add | |
| 496.16K | $27.45M | 0.01% | Add | |
| 391.17K | $21.64M | 1.33% | Add | |
| 354.00K | $19.58M | 0.03% | New | |
| 316.71K | $17.52M | 0.00% | Reduce | |
| 286.02K | $16.31M | 0.00% | Reduce | |
| 259.02K | $14.33M | 0.00% | Reduce | |
| 232.98K | $12.89M | 0.01% | Hold | |
| 212.65K | $11.76M | 0.01% | Add | |
| 177.92K | $9.84M | 0.00% | Add | |
| 175.76K | $9.72M | 0.00% | Add |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 24.07K | $1.31B | 0.18% | Add | |
| 9.46M | $516.00M | 3.35% | Reduce | |
| 8.35M | $455.35M | 0.01% | Add | |
| 5.45M | $297.20M | 1.02% | Reduce | |
| 4.75M | $259.04M | 0.03% | Add | |
| 4.75M | $259.04M | 0.03% | Add | |
| 3.22M | $175.65M | 29.17% | Hold | |
| 2.51M | $136.92M | 0.01% | New | |
| 2.51M | $136.92M | 0.01% | Add | |
| 2.05M | $111.97M | 0.07% | Reduce | |
| 2.04M | $111.19M | 10.70% | Hold | |
| 1.99M | $108.46M | 0.17% | Add | |
| 1.91M | $104.09M | 0.01% | Reduce | |
| 1.72M | $93.85M | 0.05% | Reduce | |
| 1.72M | $93.76M | 1.21% | Reduce | |
| 1.39M | $75.77M | 3.89% | Hold | |
| 1.27M | $69.18M | 0.01% | Add | |
| 1.18M | $64.46M | 0.00% | Add | |
| 1.16M | $63.00M | 0.00% | Add | |
| 1.06M | $57.73M | 3.64% | Hold | |
| 1.06M | $57.69M | 0.01% | Add | |
| 1.06M | $57.69M | 0.01% | Add | |
| 1.06M | $57.69M | 0.01% | New | |
| 1.01M | $54.98M | 0.03% | Add | |
| 879.95K | $47.99M | 0.00% | Add |
Q1 2026 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 11.31M | $538.19M | 4.19% | Add | |
| 7.68M | $365.34M | 0.01% | Add | |
| 6.11M | $290.46M | 1.23% | Add | |
| 4.73M | $224.77M | 0.03% | New | |
| 4.73M | $224.77M | 0.03% | New | |
| 3.98M | $189.45M | 0.01% | Add | |
| 3.22M | $153.21M | 25.57% | Hold | |
| 2.95M | $140.46M | 0.10% | Reduce | |
| 2.38M | $113.10M | 0.01% | Add | |
| 2.04M | $96.98M | 10.59% | Hold | |
| 1.95M | $92.98M | 0.01% | Hold | |
| 1.85M | $88.19M | 1.25% | Reduce | |
| 1.85M | $88.19M | 0.06% | Reduce | |
| 1.76M | $83.84M | 0.04% | Reduce | |
| 1.48M | $70.55M | 0.11% | Add | |
| 1.39M | $66.09M | 3.12% | Hold | |
| 1.19M | $56.46M | 0.01% | Reduce | |
| 1.14M | $54.35M | 0.00% | New | |
| 1.06M | $50.36M | 2.86% | Hold | |
| 1.04M | $49.44M | 0.01% | Add | |
| 1.04M | $49.44M | 0.01% | Add | |
| 983.07K | $46.76M | 0.00% | Reduce | |
| 968.13K | $46.05M | 0.06% | Add | |
| 802.18K | $38.16M | 0.01% | Add | |
| 668.14K | $31.78M | 0.00% | Hold |
Q4 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 10.52M | $551.78M | 3.66% | Add | |
| 7.51M | $393.73M | 0.01% | Add | |
| 5.95M | $312.03M | 1.31% | Add | |
| 5.89M | $309.02M | 0.05% | Add | |
| 3.75M | $196.83M | 0.01% | Reduce | |
| 3.23M | $169.20M | 0.11% | Reduce | |
| 3.22M | $168.89M | 21.14% | New | |
| 2.52M | $132.37M | 0.07% | Add | |
| 2.27M | $118.95M | 0.00% | Reduce | |
| 2.25M | $117.97M | 0.01% | Add | |
| 2.04M | $106.91M | 15.13% | Hold | |
| 1.96M | $102.68M | 0.06% | Reduce | |
| 1.96M | $102.61M | 1.19% | Reduce | |
| 1.95M | $102.47M | 0.01% | Add | |
| 1.39M | $72.85M | 3.43% | Hold | |
| 1.10M | $57.52M | 0.00% | Add | |
| 1.06M | $55.51M | 2.83% | Hold | |
| 1.03M | $54.02M | 0.01% | Add | |
| 1.03M | $54.02M | 0.01% | Add | |
| 907.11K | $47.57M | 0.01% | Add | |
| 899.33K | $47.16M | 0.06% | Reduce | |
| 755.11K | $39.60M | 0.01% | Reduce | |
| 667.06K | $34.98M | 0.00% | Reduce | |
| 550.40K | $28.86M | 0.04% | Hold | |
| 490.21K | $25.71M | 0.00% | Add |
Q3 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 9.79M | $634.29M | 3.78% | Reduce | |
| 7.05M | $456.92M | 0.01% | Add | |
| 5.65M | $366.13M | 0.06% | Add | |
| 4.98M | $322.89M | 1.39% | Add | |
| 4.01M | $259.71M | 0.01% | Add | |
| 3.28M | $212.75M | 0.13% | Reduce | |
| 2.36M | $153.25M | 0.00% | Add | |
| 2.16M | $140.23M | 0.08% | Reduce | |
| 2.16M | $140.18M | 1.36% | Reduce | |
| 2.14M | $138.79M | 0.01% | Add | |
| 2.04M | $132.13M | 19.11% | Add | |
| 1.89M | $122.21M | 0.01% | Reduce | |
| 1.40M | $90.60M | 0.01% | Add | |
| 1.39M | $90.04M | 4.32% | Hold | |
| 1.06M | $68.61M | 3.77% | Reduce | |
| 1.04M | $67.71M | 0.14% | Reduce | |
| 985.77K | $63.89M | 0.01% | Add | |
| 985.77K | $63.89M | 0.01% | Add | |
| 909.71K | $58.96M | 0.07% | Add | |
| 877.03K | $56.83M | 0.01% | Reduce | |
| 779.93K | $50.55M | 0.01% | Add | |
| 593.42K | $38.46M | 0.01% | Add | |
| 572.97K | $37.13M | 0.07% | Reduce | |
| 551.00K | $35.71M | 0.06% | Add | |
| 483.34K | $31.33M | 0.00% | Add |
Q2 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 10.18M | $495.28M | 3.63% | Hold | |
| 6.07M | $295.07M | 0.01% | Add | |
| 5.59M | $272.08M | 0.05% | Reduce | |
| 3.68M | $179.14M | 0.11% | Reduce | |
| 3.27M | $159.08M | 0.01% | Add | |
| 2.76M | $134.47M | 0.65% | Add | |
| 2.41M | $117.46M | 0.07% | Reduce | |
| 2.41M | $117.38M | 1.17% | Reduce | |
| 2.30M | $111.78M | 0.00% | Add | |
| 2.07M | $100.79M | 0.01% | Add | |
| 1.93M | $93.83M | 0.01% | Reduce | |
| 1.59M | $77.23M | 5.81% | Hold | |
| 1.55M | $75.20M | 0.14% | Add | |
| 1.39M | $67.57M | 4.14% | Hold | |
| 1.34M | $65.41M | 0.13% | Add | |
| 1.05M | $51.02M | 11.06% | Hold | |
| 964.69K | $46.92M | 0.01% | Reduce | |
| 933.20K | $45.39M | 0.01% | Add | |
| 933.20K | $45.39M | 0.01% | Add | |
| 917.71K | $44.64M | 0.01% | Reduce | |
| 856.89K | $41.68M | 0.05% | Reduce | |
| 761.12K | $37.02M | 0.01% | Add | |
| 511.38K | $24.87M | 0.00% | Reduce | |
| 498.56K | $24.25M | 29.52% | Hold | |
| 491.90K | $23.93M | 0.04% | Add |
New Positions (Q2 2026)
- GEODE CAPITAL MANAGEMENT, LLC 2.51M sh · $136.92M
- Sixth Street Partners Management Company, L.P. 1.06M sh · $57.69M
- Logos Global Management LP 300.00K sh · $16.36M
- Life Cycle Investment Partners Ltd 143.69K sh · $7.84M
- Campbell & CO Investment Adviser LLC 107.53K sh · $5.86M
- CREDIT AGRICOLE S A 85.93K sh · $4.69M
- STATE OF MICHIGAN RETIREMENT SYSTEM 82.55K sh · $4.50M
- Fisher Asset Management, LLC 77.96K sh · $4.25M
- Shah Wealth Advisors, LLC 69.06K sh · $3.77M
- Jupiter Topco LLC 40.27K sh · $2.20M
- Encore Global Management, LP 30.56K sh · $1.67M
- Quadrature Capital Ltd 29.17K sh · $1.59M
Fully Exited (vs previous quarter)
- STATE STREET CORP sold 3.98M sh · $189.45M
- LOOMIS SAYLES & CO L P sold 968.13K sh · $46.05M
- DIADEMA PARTNERS LP sold 106.30K sh · $5.06M
- Baker Chad R sold 93.30K sh · $4.44M
- VAN ECK ASSOCIATES CORP sold 85.29K sh · $4.06M
- Monashee Investment Management LLC sold 50.00K sh · $2.38M
- Janus Henderson Group sold 40.27K sh · $1.92M
- READYSTATE ASSET MANAGEMENT LP sold 20.93K sh · $995.78K
- Orion Porfolio Solutions, LLC sold 13.27K sh · $631.25K
- Virtu Financial LLC sold 11.59K sh · $551.00K
- GSA CAPITAL PARTNERS LLP sold 9.71K sh · $462.00K
- NWAM LLC sold 9.17K sh · $436.36K
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ARK Invest | 10.06M | 9.46M | 11.31M | 10.52M | 9.79M | 10.18M | 10.17M | 8.97M | 7.50M | 7.78M | 8.16M | 8.54M | 7.16M | 7.34M | 7.99M | 7.83M | 8.24M | 9.73M | 9.41M | 9.09M |
| BlackRock Inc | 8.30M | 8.35M | 7.68M | 7.51M | 7.05M | 6.07M | 2.61M | 2.76M | 2.80M | — | — | — | — | — | — | — | — | — | — | — |
| STATE STREET CORP | 4.99M | — | 3.98M | 3.75M | 4.01M | 3.27M | 2.41M | 2.49M | 2.99M | 2.39M | 1.50M | 1.75M | 1.88M | — | — | — | — | — | — | — |
| Capital World Investors | 4.74M | 4.75M | 4.73M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| GSK plc | 2.61M | 3.22M | 3.22M | 3.22M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Geode Capital Management | 2.51M | 2.51M | 2.38M | 2.25M | 2.14M | 2.07M | 1.05M | 1.00M | 1.01M | 973.02K | 909.30K | 883.73K | 849.94K | 834.61K | 809.98K | 789.10K | 764.68K | 714.20K | 663.09K | 66.27K |
| Fidelity Management & Research (FMR) | 1.90M | 1.91M | 1.95M | 1.95M | 1.89M | 1.93M | 1.94M | 2.22M | 2.38M | 2.35M | 2.24M | 1.84M | 2.06M | 2.09M | 2.14M | 2.18M | 2.15M | 1.62M | 1.26M | 370.72K |
| Sumitomo Mitsui Trust Group, Inc. | 1.45M | 1.72M | 1.85M | 1.96M | 2.16M | 2.41M | 2.54M | 2.75M | 2.97M | 3.15M | 3.27M | 3.37M | 3.47M | — | — | — | — | — | — | — |
| Amova Asset Management Americas, Inc. | 1.45M | 1.72M | 1.85M | 1.96M | 2.16M | 2.41M | 2.54M | 2.75M | 2.97M | 3.15M | 3.27M | 3.37M | 3.47M | — | — | — | — | — | — | — |
| Capital International Investors | 1.27M | 1.27M | 1.19M | 5.89M | 5.65M | 5.59M | 6.07M | 8.74M | 7.93M | 7.87M | 7.84M | 6.13M | 6.09M | — | — | — | — | — | — | — |
| UBS Group AG | 1.25M | 2.50K | 1.76M | 2.52M | 40.00K | 12.78K | 12.78K | 12.78K | 20.31K | 36.90K | 39.08K | 74.02K | 18.80K | 281.46K | 263.65K | 448.54K | 267.96K | 233.92K | 203.43K | 189.89K |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.17M | 1.18M | 1.14M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Morgan Stanley | 842.11K | 879.95K | 668.14K | 667.06K | 1.40M | 511.38K | 1.30M | 495.00K | 632.00K | 597.68K | 1.09M | 413.08K | 351.44K | 390.84K | 470.53K | 507.79K | 585.84K | 567.46K | 517.39K | 543.51K |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 649.73K | 648.71K | 546.83K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD FIDUCIARY TRUST CO | 573.55K | 570.04K | 542.68K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Nuveen, LLC | 496.16K | 203.09K | 190.77K | 183.38K | 182.84K | 184.85K | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 391.17K | 381.99K | 400.88K | 389.52K | 283.11K | 195.60K | 65.19K | 36.26K | 13.62K | 8.71K | — | — | — | — | — | — | — | — | — | — |
| Baird Financial Group, Inc. | 354.00K | — | — | — | — | — | — | — | — | — | 29.57K | — | — | — | — | — | — | — | — | — |
| BNY Mellon | 316.71K | 326.76K | 311.38K | 310.95K | 304.61K | 301.96K | 77.70K | 76.57K | 75.02K | 78.69K | 75.31K | 107.89K | 105.42K | 108.08K | 108.86K | 108.91K | 118.44K | 101.78K | 91.06K | 64.70K |
| JPMorgan Chase & Co | 286.02K | 431.67K | 32.00K | 53.20K | 593.42K | 10.30K | 295.99K | 400 | 400 | 400 | 26.00K | 200.00K | 520.43K | 551.39K | 538.91K | 13.50K | 13.50K | 13.50K | 13.50K | 771.90K |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold CRSP?
As of 2026-Q2, 537 institutional funds reported holding CRSP (CRISPR THERAPEUTICS AG) in SEC 13F filings, with a combined reported value of $5.64B.
How many shares of CRSP do institutions own?
13F filers reported 79.61M shares of CRSP, worth $5.64B in aggregate at the end of 2026-Q2.
Is institutional ownership of CRSP rising or falling?
Share counts moved -4.5% versus the prior quarter — distribution.
Who are the top institutional holders of CRSP?
The largest 13F holders are ARK Invest, BlackRock Inc, Orbis Allan Gray Ltd, STATE STREET CORP, Capital World Investors; the top 25 are ranked at the top of this page.
Who are the major shareholders of CRISPR THERAPEUTICS AG?
The major shareholders of CRISPR THERAPEUTICS AG (CRSP) by reported 13F value are ARK Invest, BlackRock Inc, Orbis Allan Gray Ltd, STATE STREET CORP, Capital World Investors, among 975 institutional holders.
Which legendary investors own CRSP?
1 of the legendary investors tracked on HoldingsHub report CRSP (CRISPR THERAPEUTICS AG) in their latest 13F filings, led by ARK Invest. Each is shown at that manager's own most recent quarter.
Do superinvestors agree on CRSP?
1 tracked superinvestors hold CRSP simultaneously — see the consensus page for the stocks they own together.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.